Skip to main content
Erschienen in: Obesity Surgery 11/2010

01.11.2010 | Clinical Research

Obesity and Insulin Resistance-Related Changes in the Expression of Lipogenic and Lipolytic Genes in Morbidly Obese Subjects

verfasst von: F. J. Tinahones, L. Garrido-Sanchez, M. Miranda, J. M. García-Almeida, M. Macias-Gonzalez, V. Ceperuelo, E. Gluckmann, J. Rivas-Marin, J. Vendrell, E. García-Fuentes

Erschienen in: Obesity Surgery | Ausgabe 11/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

The storage capacity of adipose tissue may be an important factor linking obesity, insulin resistance (IR), and associated morbidities. The aim of this study was to analyze the expression of lipogenic and lipolytic genes in adipose tissue and the influence of IR.

Methods

We studied the mRNA expression of peroxisome proliferator-activated receptor-γ (PPARγ) and lipogenic and lipolytic enzymes in the visceral (VAT) and subcutaneous adipose tissue (SAT) from 23 morbidly obese patients (MO; 13 with low IR and ten with high IR) and from 15 healthy, lean controls.

Results

In the VAT and SAT from the MO, we found an increased expression of PPARγ (p = 0.001 and p = 0.022, respectively), acyl-coenzyme A (CoA)/cholesterol acyltransferase (p < 0.001 and p < 0.001), aquaporin 7 (p < 0.001 and p = 0.003), and adipose triglyceride lipase (p < 0.001 and p < 0.001) and a reduced expression of acetyl-coenzyme A carboxylase (p = 0.004 and p < 0.001), independently of the state of IR. The expression of phosphoenolpyruvate carboxykinase and acyl-CoA synthetase, however, was significantly lower in the MO with high IR (p < 0.05). Glycerol kinase (p = 0.010), hormone-sensitive lipase (p < 0.001), and perilipin (p = 0.006) were only significantly increased in VAT. Acyl-CoA synthetase (p = 0.012) and fatty acid binding protein-4 (p = 0.003) were only significantly decreased in SAT. The expression of the genes studied was only greater in the SAT than the VAT in the controls.

Conclusion

Our results show an upregulation of genes facilitating triglyceride/fatty acid cycling and a reduction in the genes involved in de novo synthesis of fatty acids in morbid obesity. The expression of some of the genes studied seems to be related with the state of IR. VAT and SAT differ metabolically and also between controls and MO.
Literatur
1.
2.
Zurück zum Zitat Frayn KN. The glucose–fatty acid cycle: a physiological perspective. Biochem Soc Trans. 2003;31:1115–9.CrossRefPubMed Frayn KN. The glucose–fatty acid cycle: a physiological perspective. Biochem Soc Trans. 2003;31:1115–9.CrossRefPubMed
3.
Zurück zum Zitat Wang SJ, Cornick C, O'Dowd J, et al. Improved glucose tolerance in acyl CoA:diacylglycerol acyltransferase 1-null mice is dependent on diet. Lipids Health Dis. 2007;6:2.CrossRefPubMed Wang SJ, Cornick C, O'Dowd J, et al. Improved glucose tolerance in acyl CoA:diacylglycerol acyltransferase 1-null mice is dependent on diet. Lipids Health Dis. 2007;6:2.CrossRefPubMed
4.
Zurück zum Zitat Wang S, Soni KG, Semache M, et al. Lipolysis and the integrated physiology of lipid energy metabolism. Mol Genet Metab. 2008;95:117–26.CrossRefPubMed Wang S, Soni KG, Semache M, et al. Lipolysis and the integrated physiology of lipid energy metabolism. Mol Genet Metab. 2008;95:117–26.CrossRefPubMed
5.
Zurück zum Zitat Zimmermann R, Strauss JG, Haemmerle G, et al. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science. 2004;306:1383–6.CrossRefPubMed Zimmermann R, Strauss JG, Haemmerle G, et al. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science. 2004;306:1383–6.CrossRefPubMed
6.
Zurück zum Zitat Sztalryd C, Xu G, Dorward H, et al. Perilipin A is essential for the translocation of hormone-sensitive lipase during lipolytic activation. J Cell Biol. 2003;161:1093–103.CrossRefPubMed Sztalryd C, Xu G, Dorward H, et al. Perilipin A is essential for the translocation of hormone-sensitive lipase during lipolytic activation. J Cell Biol. 2003;161:1093–103.CrossRefPubMed
7.
Zurück zum Zitat Kalderon B, Mayorek N, Berry E, et al. Fatty acid cycling in the fasting rat. Am J Physiol Endocrinol Metab. 2000;279:E221–7.PubMed Kalderon B, Mayorek N, Berry E, et al. Fatty acid cycling in the fasting rat. Am J Physiol Endocrinol Metab. 2000;279:E221–7.PubMed
8.
Zurück zum Zitat Arner P. Control of lipolysis and its relevance to development of obesity in man. Diab Metab Rev. 1988;4:507–15.CrossRef Arner P. Control of lipolysis and its relevance to development of obesity in man. Diab Metab Rev. 1988;4:507–15.CrossRef
9.
10.
Zurück zum Zitat Semple RK, Chatterjee VK, O'Rahilly S. PPAR gamma and human metabolic disease. J Clin Invest. 2006;116:581–9.CrossRefPubMed Semple RK, Chatterjee VK, O'Rahilly S. PPAR gamma and human metabolic disease. J Clin Invest. 2006;116:581–9.CrossRefPubMed
11.
Zurück zum Zitat Festuccia WT, Laplante M, Berthiaume M, et al. PPARgamma agonism increases rat adipose tissue lipolysis, expression of glyceride lipases, and the response of lipolysis to hormonal control. Diabetologia. 2006;49:2427–36.CrossRefPubMed Festuccia WT, Laplante M, Berthiaume M, et al. PPARgamma agonism increases rat adipose tissue lipolysis, expression of glyceride lipases, and the response of lipolysis to hormonal control. Diabetologia. 2006;49:2427–36.CrossRefPubMed
12.
Zurück zum Zitat Zieleniak A, Wójcik M, Woźniak LA. Structure and physiological functions of the human peroxisome proliferator-activated receptor gamma. Arch Immunol Ther Exp (Warsz). 2008;56:331–45.CrossRef Zieleniak A, Wójcik M, Woźniak LA. Structure and physiological functions of the human peroxisome proliferator-activated receptor gamma. Arch Immunol Ther Exp (Warsz). 2008;56:331–45.CrossRef
13.
Zurück zum Zitat García-Fuentes E, García-Almeida JM, García-Arnés J, et al. Morbidly obese individuals with impaired fasting glucose have a specific pattern of insulin secretion and sensitivity: effect of weight loss after bariatric surgery. Obes Surg. 2006;16:1179–88.CrossRefPubMed García-Fuentes E, García-Almeida JM, García-Arnés J, et al. Morbidly obese individuals with impaired fasting glucose have a specific pattern of insulin secretion and sensitivity: effect of weight loss after bariatric surgery. Obes Surg. 2006;16:1179–88.CrossRefPubMed
14.
Zurück zum Zitat Soriguer F, García-Serrano S, García-Almeida JM, et al. Changes in the serum composition of free-fatty acids during an intravenous glucose tolerance test. Obesity (Silver Spring). 2009;17:10–5.CrossRef Soriguer F, García-Serrano S, García-Almeida JM, et al. Changes in the serum composition of free-fatty acids during an intravenous glucose tolerance test. Obesity (Silver Spring). 2009;17:10–5.CrossRef
15.
Zurück zum Zitat Garrido-Sánchez L, García-Almeida JM, García-Serrano S, et al. Improved carbohydrate metabolism after bariatric surgery raises antioxidized LDL antibody levels in morbidly obese patients. Diab Care. 2008;31:2258–64.CrossRef Garrido-Sánchez L, García-Almeida JM, García-Serrano S, et al. Improved carbohydrate metabolism after bariatric surgery raises antioxidized LDL antibody levels in morbidly obese patients. Diab Care. 2008;31:2258–64.CrossRef
16.
Zurück zum Zitat Kintscher U, Law RE. PPARgamma-mediated insulin sensitization: the importance of fat versus muscle. Am J Physiol Endocrinol Metab. 2005;288:E287–91.CrossRefPubMed Kintscher U, Law RE. PPARgamma-mediated insulin sensitization: the importance of fat versus muscle. Am J Physiol Endocrinol Metab. 2005;288:E287–91.CrossRefPubMed
17.
Zurück zum Zitat Garcia-Fuentes E, Murri M, Garrido-Sanchez L, et al. PPARγ expression after a high-fat meal is associated with plasma superoxide dismutase activity in morbidly obese persons. Obesity (Silver Spring). 2010;18:952–8.CrossRef Garcia-Fuentes E, Murri M, Garrido-Sanchez L, et al. PPARγ expression after a high-fat meal is associated with plasma superoxide dismutase activity in morbidly obese persons. Obesity (Silver Spring). 2010;18:952–8.CrossRef
18.
Zurück zum Zitat Macias-Gonzalez M, Moreno-Santos M, Garcia-Almeida JM, et al. PPARγ2 protects against obesity by means of a mechanism that mediates insulin resistance. Eur J Clin Invest. 2009;39:972–9.CrossRefPubMed Macias-Gonzalez M, Moreno-Santos M, Garcia-Almeida JM, et al. PPARγ2 protects against obesity by means of a mechanism that mediates insulin resistance. Eur J Clin Invest. 2009;39:972–9.CrossRefPubMed
19.
Zurück zum Zitat Medina-Gomez G, Gray SL, Yetukuri L, et al. PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet. 2007;3:e64.CrossRefPubMed Medina-Gomez G, Gray SL, Yetukuri L, et al. PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet. 2007;3:e64.CrossRefPubMed
20.
Zurück zum Zitat Chen HC, Stone SJ, Zhou P, et al. Dissociation of obesity and impaired glucose disposal in mice overexpressing acyl coenzyme a:diacylglycerol acyltransferase 1 in white adipose tissue. Diabetes. 2002;51:3189–95.CrossRefPubMed Chen HC, Stone SJ, Zhou P, et al. Dissociation of obesity and impaired glucose disposal in mice overexpressing acyl coenzyme a:diacylglycerol acyltransferase 1 in white adipose tissue. Diabetes. 2002;51:3189–95.CrossRefPubMed
21.
Zurück zum Zitat Yen CL, Stone SJ, Koliwad S, et al. Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. J Lipid Res. 2008;49:2283–301.CrossRefPubMed Yen CL, Stone SJ, Koliwad S, et al. Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. J Lipid Res. 2008;49:2283–301.CrossRefPubMed
22.
Zurück zum Zitat Zang Y, Wang T, Xie W, et al. Regulation of acetyl CoA carboxylase and carnitine palmitoyl transferase-1 in rat adipocytes. Obes Res. 2005;13:1530–9.CrossRefPubMed Zang Y, Wang T, Xie W, et al. Regulation of acetyl CoA carboxylase and carnitine palmitoyl transferase-1 in rat adipocytes. Obes Res. 2005;13:1530–9.CrossRefPubMed
23.
Zurück zum Zitat Brownsey RW, Boone AN, Elliott JE, et al. Regulation of acetyl-CoA carboxylase. Biochem Soc Trans. 2006;34:223–7.CrossRefPubMed Brownsey RW, Boone AN, Elliott JE, et al. Regulation of acetyl-CoA carboxylase. Biochem Soc Trans. 2006;34:223–7.CrossRefPubMed
24.
Zurück zum Zitat Ortega FJ, Mayas D, Moreno-Navarrete JM, et al. The gene expression of the main lipogenic enzymes is downregulated in visceral adipose tissue of obese subjects. Obesity (Silver Spring). 2010;18:13–20.CrossRef Ortega FJ, Mayas D, Moreno-Navarrete JM, et al. The gene expression of the main lipogenic enzymes is downregulated in visceral adipose tissue of obese subjects. Obesity (Silver Spring). 2010;18:13–20.CrossRef
25.
Zurück zum Zitat Kishida K, Kuriyama H, Funahashi T, et al. Aquaporin adipose, a putative glycerol channel in adipocytes. J Biol Chem. 2000;275:20896–902.CrossRefPubMed Kishida K, Kuriyama H, Funahashi T, et al. Aquaporin adipose, a putative glycerol channel in adipocytes. J Biol Chem. 2000;275:20896–902.CrossRefPubMed
26.
Zurück zum Zitat Catalán V, Gómez-Ambrosi J, Pastor C, et al. Influence of morbid obesity and insulin resistance on gene expression levels of AQP7 in visceral adipose tissue and AQP9 in liver. Obes Surg. 2008;18:695–701.CrossRefPubMed Catalán V, Gómez-Ambrosi J, Pastor C, et al. Influence of morbid obesity and insulin resistance on gene expression levels of AQP7 in visceral adipose tissue and AQP9 in liver. Obes Surg. 2008;18:695–701.CrossRefPubMed
27.
Zurück zum Zitat Ceperuelo-Mallafré V, Miranda M, Chacón MR, et al. Adipose tissue expression of the glycerol channel aquaporin-7 gene is altered in severe obesity but not in type 2 diabetes. J Clin Endocrinol Metab. 2007;92:3640–5.CrossRefPubMed Ceperuelo-Mallafré V, Miranda M, Chacón MR, et al. Adipose tissue expression of the glycerol channel aquaporin-7 gene is altered in severe obesity but not in type 2 diabetes. J Clin Endocrinol Metab. 2007;92:3640–5.CrossRefPubMed
28.
Zurück zum Zitat Arner P. Human fat cell lipolysis: biochemistry, regulation and clinical role. Best Pract Res Clin Endocrinol Metab. 2005;19:471–82.CrossRefPubMed Arner P. Human fat cell lipolysis: biochemistry, regulation and clinical role. Best Pract Res Clin Endocrinol Metab. 2005;19:471–82.CrossRefPubMed
29.
Zurück zum Zitat Mairal A, Langin D, Arner P, et al. Human adipose triglyceride lipase (PNPLA2) is not regulated by obesity and exhibits low in vitro triglyceride hydrolase activity. Diabetologia. 2006;49:1629–36.CrossRefPubMed Mairal A, Langin D, Arner P, et al. Human adipose triglyceride lipase (PNPLA2) is not regulated by obesity and exhibits low in vitro triglyceride hydrolase activity. Diabetologia. 2006;49:1629–36.CrossRefPubMed
30.
Zurück zum Zitat Tang Y, Osawa H, Onuma H, et al. Improvement in insulin resistance and the restoration of reduced phosphodiesterase 3B gene expression by pioglitazone in adipose tissue of obese diabetic KKAy mice. Diabetes. 1999;48:1830–5.CrossRefPubMed Tang Y, Osawa H, Onuma H, et al. Improvement in insulin resistance and the restoration of reduced phosphodiesterase 3B gene expression by pioglitazone in adipose tissue of obese diabetic KKAy mice. Diabetes. 1999;48:1830–5.CrossRefPubMed
31.
Zurück zum Zitat Flechtner-Mors M, Jenkinson CP, Alt A, et al. Studies of phosphodiesterase effects on adipose tissue metabolism in obese subjects by the microdialysis technique. J Physiol Pharmacol. 2005;56:355–68.PubMed Flechtner-Mors M, Jenkinson CP, Alt A, et al. Studies of phosphodiesterase effects on adipose tissue metabolism in obese subjects by the microdialysis technique. J Physiol Pharmacol. 2005;56:355–68.PubMed
32.
Zurück zum Zitat Tordjman J, Chauvet G, Quette J, et al. Thiazolidinediones block fatty acid release by inducing glyceroneogenesis in fat cells. J Biol Chem. 2003;278:18785–90.CrossRefPubMed Tordjman J, Chauvet G, Quette J, et al. Thiazolidinediones block fatty acid release by inducing glyceroneogenesis in fat cells. J Biol Chem. 2003;278:18785–90.CrossRefPubMed
33.
Zurück zum Zitat Sasaki K, Cripe TP, Koch SR, et al. Multihormonal regulation of phosphoenolpyruvate carboxykinase gene transcription. The dominant role of insulin. J Biol Chem. 1984;259:15242–51.PubMed Sasaki K, Cripe TP, Koch SR, et al. Multihormonal regulation of phosphoenolpyruvate carboxykinase gene transcription. The dominant role of insulin. J Biol Chem. 1984;259:15242–51.PubMed
34.
Zurück zum Zitat Sethi JK, Vidal-Puig AJ. Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007;48:1253–62.CrossRefPubMed Sethi JK, Vidal-Puig AJ. Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007;48:1253–62.CrossRefPubMed
35.
Zurück zum Zitat Misra A, Vikram NK. Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots. Nutrition. 2003;19:457–66.CrossRefPubMed Misra A, Vikram NK. Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots. Nutrition. 2003;19:457–66.CrossRefPubMed
36.
Zurück zum Zitat Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev. 2009;11:11–8.CrossRefPubMed Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev. 2009;11:11–8.CrossRefPubMed
37.
Zurück zum Zitat Larsen TM, Toubro S, Astrup A. PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy? Int J Obes Relat Metab Disord. 2003;27:147–61.CrossRefPubMed Larsen TM, Toubro S, Astrup A. PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy? Int J Obes Relat Metab Disord. 2003;27:147–61.CrossRefPubMed
38.
Zurück zum Zitat Large V, Arner P. Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia. Diab Metab. 1998;24:409–18. Large V, Arner P. Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia. Diab Metab. 1998;24:409–18.
Metadaten
Titel
Obesity and Insulin Resistance-Related Changes in the Expression of Lipogenic and Lipolytic Genes in Morbidly Obese Subjects
verfasst von
F. J. Tinahones
L. Garrido-Sanchez
M. Miranda
J. M. García-Almeida
M. Macias-Gonzalez
V. Ceperuelo
E. Gluckmann
J. Rivas-Marin
J. Vendrell
E. García-Fuentes
Publikationsdatum
01.11.2010
Verlag
Springer-Verlag
Erschienen in
Obesity Surgery / Ausgabe 11/2010
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-010-0194-z

Weitere Artikel der Ausgabe 11/2010

Obesity Surgery 11/2010 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.